US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist

3.300
-0.040-1.20%

Close Nov 27 16:00 ET

432.83MMarket Cap-1601P/E (TTM)

Prime Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

33.84%-25.91M

-11.44%-45.49M

-62.91%-67.71M

-25.48%-165.41M

-42.82%-43.86M

-30.13%-39.17M

-101.85%-40.82M

18.18%-41.56M

-286.79%-131.83M

-132.90%-30.71M

Net income from continuing operations

-3.57%-52.52M

-30.53%-55.33M

-16.15%-45.76M

-62.64%-198.13M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.39M

-65.26%-39.4M

26.33%-121.82M

37.56%-39.28M

Operating gains losses

----

250.00%28K

----

--8K

--0

Depreciation and amortization

26.05%1.56M

37.57%1.54M

25.00%1.32M

109.22%4.65M

43.33%1.25M

95.88%1.24M

160.00%1.12M

259.04%1.05M

291.55%2.22M

279.91%870K

Deferred tax

--0

-532.26%-134K

166.34%134K

71.06%-279K

--0

-150.94%-108K

107.01%31K

62.03%-202K

-54.49%-964K

-116.25%-202K

Other non cash items

401.59%15.73M

-357.16%-8.93M

18.26%3.35M

30.62%12.79M

19.66%3.35M

13.21%3.14M

41.93%3.47M

59.49%2.83M

-89.94%9.79M

-96.81%2.8M

Change In working capital

49.06%3.58M

256.66%8.75M

-249.48%-30.11M

107.48%2.65M

1,133.99%14.45M

162.34%2.4M

-456.70%-5.59M

74.87%-8.62M

-213.55%-35.4M

-96.29%1.17M

-Change in prepaid assets

-85.70%-6.95M

106.85%275K

-117.43%-2.79M

-444.02%-9.46M

36.93%-415K

-260.75%-3.74M

-1,098.21%-4.01M

-540.07%-1.29M

-96.38%-1.74M

-170.78%-658K

-Change in payables and accrued expense

-171.81%-6.06M

382.22%10.69M

-424.29%-23.86M

204.20%24.4M

304.78%18.29M

1,625.97%8.44M

-42.46%2.22M

85.90%-4.55M

-164.34%-23.42M

-86.47%4.52M

-Change in other current liabilities

85.43%-335K

41.66%-2.21M

-24.49%-3.46M

-19.98%-12.3M

-27.40%-3.43M

30.30%-2.3M

-94.26%-3.79M

-20.49%-2.78M

-136.67%-10.25M

-69.61%-2.69M

Cash from discontinued investing activities

Operating cash flow

33.84%-25.91M

-11.44%-45.49M

-62.91%-67.71M

-25.48%-165.41M

-42.82%-43.86M

-30.13%-39.17M

-101.85%-40.82M

18.18%-41.56M

-286.79%-131.83M

-132.90%-30.71M

Investing cash flow

Cash flow from continuing investing activities

233.29%50.34M

-75.26%6.89M

-192.40%-37.03M

139.73%18.71M

401.64%41.29M

-179.55%-37.77M

154.85%27.86M

-141.00%-12.67M

36.03%-47.1M

-212.61%-13.69M

Net PPE purchase and sale

56.10%-1.28M

3.74%-1.9M

-16.26%-2.32M

45.80%-8.72M

61.78%-1.84M

39.28%-2.91M

58.85%-1.98M

-18.42%-2M

-287.83%-16.1M

-1,160.21%-4.81M

Net investment purchase and sale

245.99%50.9M

-70.69%8.8M

-225.41%-34.71M

191.00%27.61M

586.08%43.13M

-299.78%-34.86M

166.32%30.01M

-132.82%-10.67M

56.02%-30.34M

-168.98%-8.87M

Net other investing changes

----

74.44%-170K

--0

----

-34.07%-665K

99.69%-1K

Cash from discontinued investing activities

Investing cash flow

233.29%50.34M

-75.26%6.89M

-192.40%-37.03M

139.73%18.71M

401.64%41.29M

-179.55%-37.77M

154.85%27.86M

-141.00%-12.67M

36.03%-47.1M

-212.61%-13.69M

Financing cash flow

Cash flow from continuing financing activities

12,011.01%38.51M

-53.33%35K

231,263.24%157.33M

-99.64%655K

-99.89%194K

146.56%318K

112.02%75K

105.35%68K

-32.60%181.49M

17,049.63%184.07M

Net common stock issuance

--38.08M

--0

--132.06M

--0

--185.32M

----

Proceeds from stock option exercised by employees

35.85%432K

-53.33%35K

28,241.18%19.27M

199.09%655K

24.36%194K

404.76%318K

--75K

--68K

--219K

--156K

Net other financing activities

--0

--6M

----

-272.19%-4.04M

---1.4M

Cash from discontinued financing activities

Financing cash flow

12,011.01%38.51M

-53.33%35K

231,263.24%157.33M

-99.64%655K

-99.89%194K

146.56%318K

112.02%75K

105.35%68K

-32.60%181.49M

17,049.63%184.07M

Net cash flow

Beginning cash position

-48.46%69.1M

-26.74%107.66M

-72.62%55.07M

1.29%201.12M

-6.49%57.46M

26.80%134.07M

-17.15%146.96M

1.29%201.12M

436.97%198.55M

-69.38%61.44M

Current changes in cash

182.15%62.94M

-199.28%-38.56M

197.10%52.59M

-5,780.51%-146.05M

-101.71%-2.39M

-72.98%-76.62M

82.01%-12.89M

-155.80%-54.16M

-98.41%2.57M

6,691.46%139.67M

End cash Position

129.81%132.04M

-48.46%69.1M

-26.74%107.66M

-72.62%55.07M

-6.49%57.46M

26.80%134.07M

-17.15%146.96M

1.29%201.12M

Free cash flow

35.38%-27.19M

-10.74%-47.39M

-60.77%-70.03M

-17.72%-174.14M

-28.65%-45.7M

-20.60%-42.08M

-71.02%-42.8M

17.00%-43.56M

-286.91%-147.92M

-161.82%-35.53M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	33.84%-25.91M	-11.44%-45.49M	-62.91%-67.71M	-25.48%-165.41M	-42.82%-43.86M	-30.13%-39.17M	-101.85%-40.82M	18.18%-41.56M	-286.79%-131.83M	-132.90%-30.71M
Net income from continuing operations	-3.57%-52.52M	-30.53%-55.33M	-16.15%-45.76M	-62.64%-198.13M	-67.10%-65.64M	-72.77%-50.71M	-44.42%-42.39M	-65.26%-39.4M	26.33%-121.82M	37.56%-39.28M
Operating gains losses	----	----	----	250.00%28K	----	----	----	----	--8K	--0
Depreciation and amortization	26.05%1.56M	37.57%1.54M	25.00%1.32M	109.22%4.65M	43.33%1.25M	95.88%1.24M	160.00%1.12M	259.04%1.05M	291.55%2.22M	279.91%870K
Deferred tax	--0	-532.26%-134K	166.34%134K	71.06%-279K	--0	-150.94%-108K	107.01%31K	62.03%-202K	-54.49%-964K	-116.25%-202K
Other non cash items	401.59%15.73M	-357.16%-8.93M	18.26%3.35M	30.62%12.79M	19.66%3.35M	13.21%3.14M	41.93%3.47M	59.49%2.83M	-89.94%9.79M	-96.81%2.8M
Change In working capital	49.06%3.58M	256.66%8.75M	-249.48%-30.11M	107.48%2.65M	1,133.99%14.45M	162.34%2.4M	-456.70%-5.59M	74.87%-8.62M	-213.55%-35.4M	-96.29%1.17M
-Change in prepaid assets	-85.70%-6.95M	106.85%275K	-117.43%-2.79M	-444.02%-9.46M	36.93%-415K	-260.75%-3.74M	-1,098.21%-4.01M	-540.07%-1.29M	-96.38%-1.74M	-170.78%-658K
-Change in payables and accrued expense	-171.81%-6.06M	382.22%10.69M	-424.29%-23.86M	204.20%24.4M	304.78%18.29M	1,625.97%8.44M	-42.46%2.22M	85.90%-4.55M	-164.34%-23.42M	-86.47%4.52M
-Change in other current liabilities	85.43%-335K	41.66%-2.21M	-24.49%-3.46M	-19.98%-12.3M	-27.40%-3.43M	30.30%-2.3M	-94.26%-3.79M	-20.49%-2.78M	-136.67%-10.25M	-69.61%-2.69M
Cash from discontinued investing activities
Operating cash flow	33.84%-25.91M	-11.44%-45.49M	-62.91%-67.71M	-25.48%-165.41M	-42.82%-43.86M	-30.13%-39.17M	-101.85%-40.82M	18.18%-41.56M	-286.79%-131.83M	-132.90%-30.71M
Investing cash flow
Cash flow from continuing investing activities	233.29%50.34M	-75.26%6.89M	-192.40%-37.03M	139.73%18.71M	401.64%41.29M	-179.55%-37.77M	154.85%27.86M	-141.00%-12.67M	36.03%-47.1M	-212.61%-13.69M
Net PPE purchase and sale	56.10%-1.28M	3.74%-1.9M	-16.26%-2.32M	45.80%-8.72M	61.78%-1.84M	39.28%-2.91M	58.85%-1.98M	-18.42%-2M	-287.83%-16.1M	-1,160.21%-4.81M
Net investment purchase and sale	245.99%50.9M	-70.69%8.8M	-225.41%-34.71M	191.00%27.61M	586.08%43.13M	-299.78%-34.86M	166.32%30.01M	-132.82%-10.67M	56.02%-30.34M	-168.98%-8.87M
Net other investing changes	----	----	----	74.44%-170K	--0	--0	----	----	-34.07%-665K	99.69%-1K
Cash from discontinued investing activities
Investing cash flow	233.29%50.34M	-75.26%6.89M	-192.40%-37.03M	139.73%18.71M	401.64%41.29M	-179.55%-37.77M	154.85%27.86M	-141.00%-12.67M	36.03%-47.1M	-212.61%-13.69M
Financing cash flow
Cash flow from continuing financing activities	12,011.01%38.51M	-53.33%35K	231,263.24%157.33M	-99.64%655K	-99.89%194K	146.56%318K	112.02%75K	105.35%68K	-32.60%181.49M	17,049.63%184.07M
Net common stock issuance	--38.08M	--0	--132.06M	--0	--0	--0	--0	--0	--185.32M	----
Proceeds from stock option exercised by employees	35.85%432K	-53.33%35K	28,241.18%19.27M	199.09%655K	24.36%194K	404.76%318K	--75K	--68K	--219K	--156K
Net other financing activities	--0	--0	--6M	----	----	----	----	----	-272.19%-4.04M	---1.4M
Cash from discontinued financing activities
Financing cash flow	12,011.01%38.51M	-53.33%35K	231,263.24%157.33M	-99.64%655K	-99.89%194K	146.56%318K	112.02%75K	105.35%68K	-32.60%181.49M	17,049.63%184.07M
Net cash flow
Beginning cash position	-48.46%69.1M	-26.74%107.66M	-72.62%55.07M	1.29%201.12M	-6.49%57.46M	26.80%134.07M	-17.15%146.96M	1.29%201.12M	436.97%198.55M	-69.38%61.44M
Current changes in cash	182.15%62.94M	-199.28%-38.56M	197.10%52.59M	-5,780.51%-146.05M	-101.71%-2.39M	-72.98%-76.62M	82.01%-12.89M	-155.80%-54.16M	-98.41%2.57M	6,691.46%139.67M
End cash Position	129.81%132.04M	-48.46%69.1M	-26.74%107.66M	-72.62%55.07M	-72.62%55.07M	-6.49%57.46M	26.80%134.07M	-17.15%146.96M	1.29%201.12M	1.29%201.12M
Free cash flow	35.38%-27.19M	-10.74%-47.39M	-60.77%-70.03M	-17.72%-174.14M	-28.65%-45.7M	-20.60%-42.08M	-71.02%-42.8M	17.00%-43.56M	-286.91%-147.92M	-161.82%-35.53M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data